Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather N Reich

Showing results (61-70 of 123) with videos related to

Pageof 13
Sort By:
The Journal of Molecular Diagnostics : JMD|March 1, 2011
Molecular markers of injury in kidney biopsy specimens of patients with lupus nephritisHeather N Reich, Carol Landolt-Marticorena, Paul C Boutros, et al.
Kidney International|September 16, 2011
Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritisSean J Barbour, Allen Greenwald, Ognjenka Djurdjev, et al.
Kidney International|March 27, 2026
Complement inhibitors and B-cell modifying agents for IgA nephropathy- a KDIGO commentaryBrad H Rovin, Jonathan Barratt, H Terence Cook, et al.
Kidney International|September 20, 2025
KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV), Brad H Rovin, Jonathan Barratt, et al.
Kidney International Reports|September 12, 2022
International Physicians Delphi Survey: Managing Patients With IgA NephropathyJürgen Floege, Jonathan Barratt, Rosanna Coppo, et al.
The Journal of Pediatrics|May 13, 2018
Social Determinants of Health Are Associated with Markers of Renal Injury in Adolescents with Type 1 DiabetesLaura A M Cummings, Antoine Clarke, Etienne Sochett, et al.
Rheumatology (Oxford, England)|December 16, 2010
Glomerular filtration rate predicts arterial events in women with systemic lupus erythematosusWendy Zhang, Elaheh Aghdassi, Heather N Reich, et al.
Journal of the American Society of Nephrology : JASN|January 30, 2021
Quantifying Duration of Proteinuria Remission and Association with Clinical Outcome in IgA NephropathyMark Canney, Sean J Barbour, Yuyan Zheng, et al.
Kidney International Reports|January 10, 2022
Efficacy of Rituximab in Treatment-Resistant Focal Segmental Glomerulosclerosis With Elevated Soluble Urokinase-Type Plasminogen Activator Receptor and Activation of Podocyte β3 IntegrinMichelle A Hladunewich, Dan Cattran, Sanjeev M Sethi, et al.
Kidney International Reports|September 12, 2022
Diagnosis and Treatment of Patients With Focal Segmental Glomerulosclerosis/Steroid-Resistant Nephrotic Syndrome: A Delphi SurveyJürgen Floege, Keisha L Gibson, Manuel Praga, et al.
Pageof 13

Showing results (61-70 of 123) with videos related to

Sort By:
Pageof 13
The Journal of Molecular Diagnostics : JMD|March 1, 2011
Molecular markers of injury in kidney biopsy specimens of patients with lupus nephritisHeather N Reich, Carol Landolt-Marticorena, Paul C Boutros, et al.
Kidney International|September 16, 2011
Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritisSean J Barbour, Allen Greenwald, Ognjenka Djurdjev, et al.
Kidney International|March 27, 2026
Complement inhibitors and B-cell modifying agents for IgA nephropathy- a KDIGO commentaryBrad H Rovin, Jonathan Barratt, H Terence Cook, et al.
Kidney International|September 20, 2025
KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV), Brad H Rovin, Jonathan Barratt, et al.
Kidney International Reports|September 12, 2022
International Physicians Delphi Survey: Managing Patients With IgA NephropathyJürgen Floege, Jonathan Barratt, Rosanna Coppo, et al.
The Journal of Pediatrics|May 13, 2018
Social Determinants of Health Are Associated with Markers of Renal Injury in Adolescents with Type 1 DiabetesLaura A M Cummings, Antoine Clarke, Etienne Sochett, et al.
Rheumatology (Oxford, England)|December 16, 2010
Glomerular filtration rate predicts arterial events in women with systemic lupus erythematosusWendy Zhang, Elaheh Aghdassi, Heather N Reich, et al.
Journal of the American Society of Nephrology : JASN|January 30, 2021
Quantifying Duration of Proteinuria Remission and Association with Clinical Outcome in IgA NephropathyMark Canney, Sean J Barbour, Yuyan Zheng, et al.
Kidney International Reports|January 10, 2022
Efficacy of Rituximab in Treatment-Resistant Focal Segmental Glomerulosclerosis With Elevated Soluble Urokinase-Type Plasminogen Activator Receptor and Activation of Podocyte β3 IntegrinMichelle A Hladunewich, Dan Cattran, Sanjeev M Sethi, et al.
Kidney International Reports|September 12, 2022
Diagnosis and Treatment of Patients With Focal Segmental Glomerulosclerosis/Steroid-Resistant Nephrotic Syndrome: A Delphi SurveyJürgen Floege, Keisha L Gibson, Manuel Praga, et al.
Pageof 13